Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-12-23

Clinical Trial Update: Jiangzhuo Prescription ,Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)

View source ↗

Summary

This is a clinical trial update comparing Jiangzhuo Prescription, Fenofibrate, and a placebo for hyperlipidemia and metabolic syndrome, sponsored by Guang'anmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Jiangzhuo Prescription

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Metabolic Syndromes, Hyperlipidemia | Status: UNKNOWN